JP Morgan Chase
CMD

JP Morgan Chase’s Cantel Medical Corporation CMD Stock Holding History

JP Morgan Chase’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,872,392
Closed -$149M – 6814
2021
Q1 		$149M Buy
1,872,392
+312,814
+20% +$24.4M 0.02% 674
2020
Q4 		$123M Buy
1,559,578
+290,184
+23% +$17M 0.02% 704
2020
Q3 		$56.7M Buy
1,269,394
+1,228,477
+3,002% +$60.5M 0.01% 913
2020
Q2 		$1.81M Sell
40,917
-15,127
-27% -$564K ﹤0.01% 3172
2020
Q1 		$2.01M Sell
56,044
-803
-1% -$45.7K ﹤0.01% 2962
2019
Q4 		$4.03M Sell
56,847
-1,670
-3% -$121K ﹤0.01% 2855
2019
Q3 		$4.38M Buy
58,517
+14,798
+34% +$1.25M ﹤0.01% 2805
2019
Q2 		$3.39M Sell
43,719
-8,855
-17% -$623K ﹤0.01% 2960
2019
Q1 		$3.52M Sell
52,574
-22,905
-30% -$1.73M ﹤0.01% 2888
2018
Q4 		$5.62M Sell
75,479
-3,050
-4% -$252K ﹤0.01% 2474
2018
Q3 		$7.23M Sell
78,529
-103,770
-57% -$9.88M ﹤0.01% 2456
2018
Q2 		$17.9M Buy
182,299
+118,404
+185% +$13.2M ﹤0.01% 1682
2018
Q1 		$7.12M Sell
63,895
-39,043
-38% -$4.38M ﹤0.01% 2286
2017
Q4 		$10.6M Buy
102,938
+65,458
+175% +$6.52M ﹤0.01% 2078
2017
Q3 		$3.41M Buy
37,480
+7,917
+27% +$625K ﹤0.01% 2836
2017
Q2 		$2.3M Sell
29,563
-29,888
-50% -$2.24M ﹤0.01% 2953
2017
Q1 		$4.76M Sell
59,451
-54,503
-48% -$4.33M ﹤0.01% 2464
2016
Q4 		$8.97M Buy
113,954
+85,114
+295% +$6.61M ﹤0.01% 1997
2016
Q3 		$2.25M Buy
28,840
+27,874
+2,886% +$2.02M ﹤0.01% 2727
2016
Q2 		$66K Buy
966
+762
+374% +$52.6K ﹤0.01% 3981
2016
Q1 		$15K Buy
204
+13
+7% +$816 ﹤0.01% 4161
2015
Q4 		$12K Buy
+191
New +$11.7K ﹤0.01% 4183
2014
Q1 		– Sell
-40,008
Closed -$1.36M – 4030
2013
Q4 		$1.36M Buy
40,008
+2,350
+6% +$81.4K ﹤0.01% 2990
2013
Q3 		$1.2M Sell
37,658
-13,927
-27% -$370K ﹤0.01% 3150
2013
Q2 		$1.17M Buy
+51,585
New +$1.12M ﹤0.01% 3155

JP Morgan Chase's CMD Position: Q2 2021 in Review

JP Morgan Chase sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,872,392 shares — an estimated $149M sold.

JP Morgan Chase first reported a position in CMD in Q2 2013 and held it in 25 quarters. The position peaked at $149M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • JP Morgan Chase reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • JP Morgan Chase sold 1,872,392 Cantel Medical Corporation shares in Q2 2021, an estimated $149M.
  • JP Morgan Chase first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 25 quarters.
  • JP Morgan Chase's Cantel Medical Corporation position peaked at $149M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.